Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo

BACKGROUND: The incidence of colorectal cancer (CRC) is on the rise. Furthermore, late-stage diagnoses and limited efficacious treatment options make CRC a complex clinical challenge. Therefore, a new therapeutic regimen with a completely novel therapeutic mechanism is necessary for CRC. In the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Lei, Zhao, Chunhong, Han, Jixia, Li, Zengjun, Zhen, Yanan, Xiao, Ruixue, Xu, Zhongfa, Sun, Yanlai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308569/
https://www.ncbi.nlm.nih.gov/pubmed/28223815
http://dx.doi.org/10.2147/TCRM.S128575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308569/
https://www.ncbi.nlm.nih.gov/pubmed/28223815
http://dx.doi.org/10.2147/TCRM.S128575

Ejemplares similares